The retrospective study, conducted from January 2020 to November 2023, followed patients for up to 3 years
In one clinical trial, EGCG is able to decrease albuminuria and ameliorate DKD ( via inhibiting Keap1 and upregulating Nrf2-ARE signaling pathway (Wang et al., 2015c
In theory, this can be calculated by: Maximum Current Draw = Capacity x C-Rating Drawing more current than specified by the C-rating is not recommended, as the battery can overheat, increase internal resistance over time, shorten battery lifespan, or even cause thermal runaway (catching fire) in extreme cases
I'm really loving this stuff
Others find evening dosing more convenient without apparent difference in results
It also means the dosing window is more flexible than peptides that require precise timing around growth hormone release patterns